Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of three Vonoprazan-based regimens for Helicobacter pylori eradication
IRCT20200422047167N2Phase 3Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vonoprazan in Helicobacter pylori infection (3 arms), sponsored by Shiraz University of Medical Sciences. Started Jul 2026; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20200422047167N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200422047167N2.